Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) Restructuring Costs (2024)

Outset Medical (OM) has disclosed Restructuring Costs for 1 consecutive years, with $1.5 million as the latest value for Q4 2024.

  • On a quarterly basis, Restructuring Costs changed N/A to $1.5 million in Q4 2024 year-over-year; TTM through Dec 2024 was $5.6 million, a N/A change, with the full-year FY2024 number at $1.5 million, down 40.0% from a year prior.
  • Restructuring Costs was $1.5 million for Q4 2024 at Outset Medical, up from $1.4 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $2.7 million in Q1 2024 to a low of $1.4 million in Q3 2024.